Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for
Gastroesophageal-junction Cancer, Monoclonal Antibody,
Location: Houston TX, Webster TX, Austin TX, Denton TX,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT06532006

Phase 3, Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumor
Location: Houston TX, Austin TX, Grand Rapids MI, Fort Worth TX,
Sponsor: Pliant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06270706

Phase 1, Recruiting

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

for
Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia,
Location: Houston TX, Miami FL
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06566742

Phase 2, Recruiting

Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases

for
Neural Tube Defects
Location: Houston TX
Sponsor: Michael A Belfort

Sex: Female

Age: 18+

Code: NCT05672849

Recruiting

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

for
Multiple Endocrine Neoplasia, Pancreatic Neuroendocrine Tumors,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT03053999

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

for
Solid Tumor
Location: Houston TX, Dallas TX, Lewisville TX, Glendale CA
Sponsor: Teligene US

Sex: All

Age: 18+

Code: NCT06010342

Phase 2, Recruiting

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: Houston TX, San Antonio TX, Denver CO, Lake Mary FL,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06907043

Phase 1, Phase 2, Recruiting

Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus

for
Post-hemorrhagic Hydrocephalus (PHH)
Location: Houston TX
Sponsor: Eva Sevick

Sex: All

Age: 0

Code: NCT06994949

Phase 1, Recruiting

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

for
Pancreatitis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03099850

Recruiting

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

for
Malignant Primary Pelvic Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT05134142

Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Houston TX, Austin TX, San Antonio TX, Dallas TX,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

for
Post-ligation Cardiac Syndrome
Location: Houston TX, Dallas TX, Oklahoma City OK, Memphis TN,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT06679855

Phase 3, Recruiting

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

for
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer,
Location: Houston TX, Memphis TN, Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 2 - 25

Code: NCT06458036

Phase 2, Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

for
NSCLC Stage IV
Location: Shenandoah TX, Hot Springs AR, Springdale AR,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase 3, Recruiting

A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

for
Oligometastatic Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06004336

Phase 2, Recruiting

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

for
Castration-Resistant Prostate Carcinoma,
Location: Houston TX, Sugar Land TX, League City TX, Conroe TX,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT06470243

Phase 3, Recruiting

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

for
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Location: Houston TX, Tampa FL
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06616636

Phase 1, Recruiting

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

for
Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05536349

Phase 2, Recruiting

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

for
Solid Tumor, Adult Lymphoma
Location: Houston TX, Pittsburgh PA, Duarte CA
Sponsor: Cyclacel Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05358379

Phase 1, Phase 2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Houston TX, Austin TX, Corpus Christi TX,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting
Article preview image

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City